Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerAnnals of oncology, 2021-09, Vol.32 (9), p.1148-1156 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.06.002 ;PMID: 34116144Full text available |
|
2 |
Material Type: Article
|
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancerBreast cancer research and treatment, 2021-01, Vol.185 (1), p.183-194 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2020 ;COPYRIGHT 2021 Springer ;Springer Science+Business Media, LLC, part of Springer Nature 2020. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-05935-5 ;PMID: 32980945Full text available |
|
3 |
Material Type: Article
|
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramAnnals of oncology, 2018-02, Vol.29 (2), p.405-417 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx651 ;PMID: 29092024Full text available |
|
4 |
Material Type: Article
|
Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscapeESMO open, 2021-08, Vol.6 (4), p.100204, Article 100204 [Peer Reviewed Journal]2021 The Author(s) ;2021 The Author(s) 2021 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1016/j.esmoop.2021.100204 ;PMID: 34225076Full text available |
|
5 |
Material Type: Article
|
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debateAnnals of oncology, 2022-03, Vol.33 (3), p.347-349 [Peer Reviewed Journal]2021 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.11.016 ;PMID: 34861375Full text available |
|
6 |
Material Type: Article
|
Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancerBreast cancer research and treatment, 2022-04, Vol.192 (2), p.293-301 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 ;2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;COPYRIGHT 2022 Springer ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06477-0 ;PMID: 34982322Full text available |
|
7 |
Material Type: Article
|
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitorsSupportive care in cancer, 2018-03, Vol.26 (3), p.869-878 [Peer Reviewed Journal]Springer-Verlag GmbH Germany 2017 ;COPYRIGHT 2018 Springer ;Supportive Care in Cancer is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-017-3903-5 ;PMID: 28963584Full text available |
|
8 |
Material Type: Article
|
Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported resultsBreast cancer research and treatment, 2021-04, Vol.186 (3), p.715-722 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-06063-w ;PMID: 33452953Full text available |
|
9 |
Material Type: Article
|
ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisibESMO open, 2021-02, Vol.6 (1), p.100018-100018, Article 100018 [Peer Reviewed Journal]2020 The Author(s) ;2020 The Author(s) 2020 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1016/j.esmoop.2020.100018 ;PMID: 33399081Full text available |
|
10 |
Material Type: Article
|
ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancerESMO open, 2021-02, Vol.6 (1), p.100017-100017, Article 100017 [Peer Reviewed Journal]2020 The Author(s) ;2020 The Author(s) 2020 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1016/j.esmoop.2020.100017 ;PMID: 33399080Full text available |
|
11 |
Material Type: Article
|
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancerBreast cancer research and treatment, 2018-08, Vol.171 (1), p.131-141 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4827-6 ;PMID: 29766363Full text available |
|
12 |
Material Type: Article
|
Risk-reducing mastectomy in BRCA carriers: survival is not the issueBreast cancer research and treatment, 2020, Vol.179 (1), p.251-252 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2019 ;COPYRIGHT 2020 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-019-05440-4 ;PMID: 31541380Full text available |
|
13 |
Material Type: Article
|
Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785]Annals of oncology, 2023-03, Vol.34 (3), p.326-326 [Peer Reviewed Journal]2022 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2022.11.010 ;PMID: 36529568Full text available |
|
14 |
Material Type: Article
|
Intrahepatic mitomycin C infusion in breast cancer liver metastasesAnnals of oncology, 2019-05, Vol.30, p.iii57-iii58 [Peer Reviewed Journal]2019 THE AUTHORS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz100.029 ;PMID: 32084862Full text available |
|
15 |
Material Type: Article
|
Differences between breast cancer subtypes in developing metastatic diseaseAnnals of oncology, 2019-05, Vol.30, p.iii50-iii50 [Peer Reviewed Journal]2019 THE AUTHORS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz100.008 ;PMID: 32084841Full text available |
|
16 |
Material Type: Article
|
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survivalBreast cancer research and treatment, 2019-08, Vol.176 (3), p.597-605 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2019 ;COPYRIGHT 2019 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-019-05254-4 ;PMID: 31065871Full text available |
|
17 |
Material Type: Article
|
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaborationESMO open, 2021-04, Vol.6 (2), p.100058, Article 100058 [Peer Reviewed Journal]2021 ESMO ;Copyright © 2021 ESMO. Published by Elsevier Ltd.. All rights reserved. ;2021 ESMO 2021 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1016/j.esmoop.2021.100058 ;PMID: 33601295Full text available |
|
18 |
Material Type: Article
|
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortJournal of cancer research and clinical oncology, 2021-04, Vol.147 (4), p.1041-1048 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 ;The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-020-03487-1 ;PMID: 33471187Full text available |
|
19 |
Material Type: Article
|
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey seriesESMO open, 2022-02, Vol.7 (1), p.100374, Article 100374 [Peer Reviewed Journal]2021 ;Copyright © 2021. Published by Elsevier Ltd. ;2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2021 ;ISSN: 2059-7029 ;EISSN: 2059-7029 ;DOI: 10.1016/j.esmoop.2021.100374 ;PMID: 35007996Full text available |
|
20 |
Material Type: Article
|
Breast cancer subtype and survival by parity and time since last birthBreast cancer research and treatment, 2018-06, Vol.169 (3), p.481-487 [Peer Reviewed Journal]Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4701-6 ;PMID: 29426984Full text available |